/Sponsor / Executive Profile

Chris Kim

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Mr. Chris Kim has been Liminatus Pharma, LLC’s Chief Executive Officer and Managing Member since its founding in May 2018.

Total Capital Deployed

$200,000,000

Active / Searching Capital:
-

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
LIMN
Iris Acquisition Corp
closed
-
$10.00
-Jun 2025Done
250.0M
GeneralCantor Fitzgerald & Co.
IRAA
Tribe Capital Growth Corp I
closed
200.0M
$10.00
1/3Jan 2021Done
175.0M
BiopharmaceuticalCantor Fitzgerald & Co.